SCHEMBL29562065

SCHEMBL29562065

Cc1c(Oc2cc(Cl)cc(N)c2F)ccc([N+](=O)[O-])c1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.35
▸ EPAS1 Q99814 2/20 0.34
▸ MAPT P10636 4/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TTR P02766 1/20 0.34
▸ PPOX P50336 1/20 0.34
▸ PDE7A Q13946 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22831892 1.00 LMNA (0.40) LMNAPOLBSMN1; SMN2TDP1EPAS1
SCHEMBL22831965 0.90 LMNA (0.35) LMNAPOLBSMN1; SMN2TDP1MAPT
SCHEMBL29562048 0.90 LMNA (0.35) LMNAPOLBSMN1; SMN2MAPTKMT2A
SCHEMBL29561992 0.90 LMNA (0.35) LMNAPOLBSMN1; SMN2TDP1MAPT
SCHEMBL22832036 0.90 LMNA (0.35) LMNAPOLBSMN1; SMN2MAPTKMT2A
SCHEMBL22832147 0.87 GRM6 (0.36) EPAS1
SCHEMBL29562072 0.85 GRM6 (0.35) LMNAPOLBSMN1; SMN2TDP1MAPT
SCHEMBL22832130 0.85 GRM6 (0.35) LMNAPOLBSMN1; SMN2TDP1MAPT
SCHEMBL22832025 0.83 HSPB1 (0.34) LMNAPOLBSMN1; SMN2TDP1MAPT
SCHEMBL29562112 0.83 HSPB1 (0.34) LMNAPOLBSMN1; SMN2TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990437-A1 QUINAZOLIN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS Array Biopharma, Inc. (US) 2022-05-04 — — EP disclosed
Send feedback